Dexmedetomidine Versus Midazolam for Peribulbar Block
Key facts
- Who runs it
- Suez Canal University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 50 people enrolled
- Started
- 1 Dec 2023
- Ended
- 30 Sept 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Dexmedetomidine as an adjuvant to local anesthesia for peribulbar block
- Midazolam as an adjuvant to local anesthesia for peribulbar block
- Record updated
- 30 April 2025
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Clinical diagnosis of cataract Disease
- Scheduled for cataract surgery
- American Society of Anesthesiologists physical status I or II
Who cannot take part
- History of allergy to any of the study medications
- Had severe cardiac disease
- Had chronic obstructive lung disease
- Had a history of sleep apnea
- Had impaired mental status
- Had coagulation abnormalities
- Refused to participate
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
50 patients of both sexes, ages 18 to 75, who were scheduled for cataract surgery and had physical status I or II according to the American Society of Anesthesiologists were included in this study.
Read full original descriptionShow less
After induction of general anesthesia, all patients received peribulbar block. In group A (midazolam group), 25 patients received midazolam. In group B (dexmedetomidine group), 25 patients received dexmedetomidine.
The 2 groups in the trial
- peribulbar block 1Existing treatment, for comparison
Patients who were scheduled for cataract surgery under peribulbar block.
Treatment: Dexmedetomidine as an adjuvant to local anesthesia for peribulbar block
- peribulbar block 2Existing treatment, for comparison
Patients who were scheduled for cataract surgery under peribulbar block.
Treatment: Midazolam as an adjuvant to local anesthesia for peribulbar block
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Dexmedetomidine Versus Midazolam as an Adjuvant to Local Anesthetic Mixture (Bupivacaine, Lidocaine, and Hyaluronidase) for Peribulbar Block During Cataract Surgery: A Randomized Controlled Trial
- Record updated
- 30 April 2025